Proactive Investors - Run By Investors For Investors

Flowr to raise C$15 million to advance Holigen operations; announces C-suite changes

The Toronto-based company says founder and co-CEO Tom Flow will pivot to a new role
cannabis plant
The financing is led by the cannabis company’s management team

The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) is raising C$15 million to help fund construction of cultivation facilities in Portugal and Australia, the company announced Tuesday.

Flower is planning to complete a non-brokered private placement of up to 2.4 million shares at C$6.25 per share for proceeds of $15 million.

READ: Flowr reports revenue bump in 4Q as it scales up Kelowna facility

The financing is led by the cannabis company’s management team, which is investing an aggregate of $3.6 million, including CEO Vinay Tolia and Chairman Steve Klein through the Core Flow subsidiary.

“Through leading each round of financing for the company, Core Flow has a strong conviction in Flowr’s edge in designing and constructing highly efficient facilities and producing high quality cannabis products,” said Klein.  “Moreover, Flowr is building a company, from its management team to cultivators, that I believe is second to none."

Personnel changes

Amid a flutter of changes, it was announced that Tom Flow is transitioning from his role as co-CEO and board member to the position of founder and managing partner.

Personnel changes at the board of directors and management level include Thierry Elmaleh joining Flowr as head of capital markets, having spent nearly 15 years in investment banking at BMO Capital Markets and Bank of America Merrill Lynch.

And Don Duet, former technology partner at Goldman Sachs, joins Flowr’s board of directors.

Current lead independent director Rishi Shah is stepping down from the role to be replaced by Karen Basian.

Updates on Holigen investment

The Toronto-based cannabis cultivator is closing a nearly 20% investment in Holigen Holdings Ltd, a European-based cannabis company developing large-scale GMP-compliant grow facilities in Portugal and Australia.

In Portugal, Holigen is building a 21,500 square foot installation for cultivation, processing, GMP manufacturing and R&D operations. The company is also initiating the installation of one of the largest outdoor cultivation areas for cannabis sativa (THC).

In Australia, Holigen is expected to begin construction on a manufacturing facility for medicinal cannabis, with the aim to be in production by the end of 2019.

Flowr shares were trading at C$6.58 in Toronto and at US$4.90 in the US at Monday’s close.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full FLWR profile View Profile

The Flowr Corporation Timeline

Newswire
May 23 2019

Related Articles

cannabis
June 08 2019
1933 Industries is progressing with plans to launch one of Nevada's largest hemp extraction facilities, amid a flurry of other activity
cannabis flower
April 26 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
cannabis leaf
May 08 2019
The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use